Topical Hemostat Market Report 2026

Topical Hemostat Market Overview

• Topical Hemostat market size has reached to $5.45 billion in 2025 • Expected to grow to $8.53 billion in 2030 at a compound annual growth rate (CAGR) of 9.3% • Growth Driver: Growing Surgical Procedures Are Fueling The Market Growth Due To Increasing Industrialization And Production Needs • Market Trend: Innovative Hemostatic Sealing Patches Revolutionize Surgical Bleeding Control • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Topical Hemostat Market?

A topical hemostat refers to a specialized medical product designed to be applied directly to a bleeding site during surgical or traumatic procedures to promote rapid blood clotting and effectively control bleeding. These hemostatic agents work locally by creating a physical barrier, activating the body’s natural clotting mechanisms, or providing a supportive matrix that facilitates platelet aggregation and fibrin formation to stop bleeding. The main types of topical hemostats are fibrin, thrombin, cellulose, collagen, gelatin, adhesives, and others. Fibrin hemostats refer to biologically derived agents that mimic the final stages of the coagulation cascade by combining fibrinogen and thrombin to form a stable fibrin clot at the site of bleeding. These products are distributed through various channels such as direct sales, distributors, hospital pharmacies, and online and used across a range of applications, including general surgery, neurosurgery, vascular surgery, cardiovascular surgery, and others. Key end users of these hemostats include hospitals, ambulatory surgical centers, and others.

What Is The Topical Hemostat Market Growth Forecast?

The topical hemostat market size is expected to see strong growth in the next few years. It will grow to $8.53 billion in 2030 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to growing adoption of bioactive and combination hemostats, integration with AI and digital surgery platforms, expansion of ambulatory surgical centers, focus on patient-specific hemostatic solutions, emerging markets surgical infrastructure growth. Major trends in the forecast period include minimally invasive surgical hemostasis, advanced bioactive hemostats development, patient-specific hemostatic solutions, growth in emergency & trauma care applications, expansion of outpatient & ambulatory surgical procedures.

Global Topical Hemostat Market Segmentation

1) By Type: Fibrin, Thrombin, Cellulose, Collagen, Gelatin, Adhesives, Other Types 2) By Distribution Channel: Direct Sales, Distributors, Hospital Pharmacies, Online 3) By Application: General Surgery, Neurosurgery, Vascular Surgery, Cardiovascular Surgery, Other Applications 4) By End-Use: Hospitals, Ambulatory Surgical Centers, Other End-Uses Subsegments: 1) By Fibrin: Fibrin Sealants, Fibrin Patches 2) By Thrombin: Human Thrombin, Bovine Thrombin, Recombinant Thrombin 3) By Cellulose: Oxidized Regenerated Cellulose, Oxidized Non-Regenerated Cellulose, Microfibrillar Cellulose 4) By Collagen: Microfibrillar Collagen, Collagen Sponges, Collagen Fleece 5) By Gelatin: Gelatin Sponges, Gelatin Foams, Gelatin Powder 6) By Adhesives: Cyanoacrylate-Based Adhesives, Polyethylene Glycol Based Sealants, Albumin And Glutaraldehyde-Based Adhesives 7) By Other Types: Combination Hemostats, Polysaccharide-Based Hemostats, Chitosan-Based Hemostats

What Is The Driver Of The Topical Hemostat Market?

The growing number of surgical procedures is expected to propel the growth of the topical hemostat market going forward. Surgical procedures refer to medical interventions surgeons perform involving manual techniques and specialized instruments to diagnose, treat, or repair injuries, diseases, or bodily abnormalities. The number of surgical procedures is increasing significantly as the global population ages rapidly, resulting in a greater incidence of age-related health conditions that require surgical intervention to improve quality of life and manage chronic illnesses. Topical hemostats are used in surgical procedures to help surgeons control bleeding quickly at the surgical site, ensure better visibility, reduce blood loss, and minimize the risk of postoperative complications. For instance, in January 2025, according to the Intuitive Surgical Inc., a US-based medical device company, OUS general surgery procedures increased by roughly 35% in 2024, following growth of about 42% in 2023. Colorectal procedures accounted for the largest share of incremental volume in both years. Therefore, the growing number of surgical procedures is driving the growth of the topical hemostat industry.

Key Players In The Global Topical Hemostat Market

Major companies operating in the topical hemostat market are Pfizer Inc, Johnson And Johnson, Medtronic Plc, Medline Industries, Stryker Corporation, Baxter International, Meril Life Sciences Pvt Ltd, Teleflex Incorporated, Samyang Holdings, Integra LifeSciences, B Braun SE, Advanced Medical Solutions Group Plc, Axio Biosolutions, Marine Polymer Technologies Inc, Hangzhou Singclean Medical Products, Neo Modulus Medical Sci-Tech, Tricol Biomedical, HemCon Medical Technologies Inc, Hemostasis LLC, KATSAN Medical Devices, Zhejiang Perfectseal New Materials, Z Medica LLC, Arch Therapeutics Inc, Medcura Inc

Global Topical Hemostat Market Trends and Insights

Major companies operating in the topical hemostat market are focusing on developing innovative products, such as hemostatic sealing patches, to enhance bleeding control during surgical procedures by providing faster, more effective, and targeted hemostasis at the wound site. A hemostatic sealing patch is a medical device made from materials such as collagen or fibrin that quickly stops bleeding by sticking to the tissue and helping to form a clot during surgery. For instance, in November 2023, Ethicon, Inc., a US-based company specializing in surgical technologies and solutions, introduced the ETHIZIA Hemostatic Sealing Patch, a novel synthetic polymer-based adjunctive hemostat clinically proven to stop disruptive bleeding on internal organs rapidly. In clinical trials, ETHIZIA stopped bleeding within 30 seconds in 80% of patients, six times faster than leading fibrin sealant patches. The patch is uniquely designed to be equally effective on both sides and highly adaptable, allowing it to be trimmed, rolled, pulled apart, or tailored for use in both open and minimally invasive surgeries. It dehydrates blood and accelerates coagulation through a gelatin carrier impregnated with polyoxazoline polymer, forming a strong adhesive hydrogel that bonds to tissue.

What Are Latest Mergers And Acquisitions In The Topical Hemostat Market?

In May 2025, Merit Medical Systems Inc., a US-based global healthcare technology company, acquired Biolife Delaware LLC, for approximately $120 million. Through this acquisition, Merit aims to enhance its bleeding control solutions by integrating Biolife’s patented topical hemostatic devices, including StatSeal and WoundSeal, thereby broadening its offering in the topical hemostat market. BioLife Delaware LLC is a US-based manufacturer of hemostatic dressings designed to promptly seal bleeding sites and reduce complications in interventional and surgical procedures.

Regional Outlook

North America was the largest region in the topical hemostat market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Topical Hemostat Market?

The topical hemostat market consists of sales of physical hemostats, active coagulation agents, synthetic and hemisynthetic agents, natural and plant-based agents, and chitosan-based dressings. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.